Currently, we know more than 2,000 inherited metabolic diseases. To diagnose, treat, and monitor all of them, we need a generic approach to target groups of diseases effectively. Vitamin-derived coenzymes function as major hub molecules in metabolism, connecting many reactions. Therefore, they provide a promising starting point for nutritional therapies. The European HubMOL consortium brings together an international and interdisciplinary group of scientists to train PhD students in all aspects of coenzyme metabolism, from basic science to clinical and industrial applications. As one of the HubMOL nodes, the UMCG Laboratory of Pediatrics has a vacancy for a PhD student (https://uit.no/research/hubmol, doctoral candidate 15, DC15). The candidate will study the interplay between fatty-acid oxidation and coenzyme A metabolism, in order to develop novel nutrition-based therapies for inherited metabolic diseases in which coenzyme A plays a role.
Job Description
The PhD candidate will use computational models, cell culture and organoids (in vitro-cultured mini organs), to study the impact of enzyme deficiencies in the mitochondrial fatty-acid oxidation and coenzyme A biosynthesis pathways. He/she will apply various mass spectrometry approaches to measure metabolite concentrations and fluxes, through stable-isotope incorporation. He/she will also use computational models to analyse isotope-enrichment kinetics and systemic effects of coenzyme A in metabolism. HubMOL PhD students will collaborate with each other internationally and across disciplines. An internship in one of the other HubMOL laboratories will be part of the project.